Check-Cap Ltd. (CHEK)

[Milo1]

Absolutely! European approval!

Superior product as compared to the "other" pill which was bought out for a ton of money, but turned out to be defective in giving too many false positives.

Technicals here are predicting a PPS rebound. Short Gap up to $2, where CHEK goes from there depends on the interest of large pharm buyout options, and eventual FDA certification. I've seen other biotech co. rise 1000% after a CE approval on rising investor interest alone.

European Certification will allow marketing and further studies to occur concurrently, which will then apply to the eventual FDA approval process.

Just my 2 bits, but Looking good here!